v3.25.2
Related Party Transactions (Tables)
6 Months Ended
Jun. 30, 2025
Related Party Transactions [Abstract]  
Schedule of Remuneration Attributed to Key Management Personnel

Remuneration attributed to key management personnel are summarized as follows:

 

   Three months ended
June 30,
2025
   Three months ended
June 30,
2024
   Six months ended
June 30,
2025
   Six months ended
June 30,
2024
 
Consulting fees  $147,700    80,000    595,400    160,833 
Director fees   83,290    
-
    83,290    
-
 
Salaries   
-
    170,641    26,228    377,656 
Share-based compensation   15,842    (54,859)   36,616    (32,583)
   $246,832    195,782    741,534    505,906 
Schedule of Fair Value, as Calculated on the Grant Date, to Each Related Party

Details of the fair value, as calculated on the grant date, to each related party in the current and prior periods, and the related expense recorded for the six months ended June 30, 2025 and 2024 is as follow:

 

   Six Months Ended
June 30,
2025
   Six Months Ended
June 30,
2024
   Grant date
fair value
 
Braeden Lichti, Non-executive Chairman  $11   $(5,355)  $50,995 
Graydon Bensler, CEO, CFO and Director   11    1,502    50,995 
Jordan Plews, Former Director and former CEO of Skincare and BioSciences2   11    1,502    50,995 
Tim Sayed, Former Chief Medical Officer and Former Director1   
-
    1,502    50,995 
Jeffrey Parry, Director   6,428    13,349    107,669 
Crystal Muilenburg, Former Director1   
-
    (41,668)   210,245 
Julie Daley, Director   19,592    53,643    210,245 
George Kovalyov, Director   10,563    10,308    52,845 
Brenda Buechler, Former Chief Marketing Officer1   
-
    (36,918)   143,671 
Christoph Kraneiss, Former Chief Commercial Officer1   
-
    (30,448)   121,243 
   $36,616   $(32,583)  $1,049,898 

 

1379 options of related parties were forfeited and or cancelled during the year ended December 31, 2024

 

2143 options of Jordan Plews were cancelled during the three months ended June 30, 2025